SC Pharmaceuticals(002693)

Search documents
A股五张图:原因找到了……但题材已经切换了!





Xuan Gu Bao· 2025-04-24 10:35
Market Overview - The overall market sentiment is low, with the Shanghai Composite Index closing up 0.03%, while the Shenzhen Component and ChiNext Index fell by 0.58% and 0.68% respectively, with over 3,600 stocks declining and more than 1,500 stocks rising [3] Cross-Border Payment Sector - The cross-border payment sector experienced a strong opening on Monday, driven by a favorable policy announcement from the central bank and other departments regarding the enhancement of the CIPS system [6][7] - On Wednesday, the sector saw a spike due to a scheduled press conference by the central bank to discuss the same policy, which led to a temporary surge in stocks like Huafeng Super Fiber, which rose over 15% [7][9] - However, the sector closed down 3.58% after a series of ups and downs, indicating a lack of sustained momentum [9] Pet Economy Sector - The pet economy sector opened strong, with stocks like Zhongchong Co., Tianyuan Pet, and Yiyi Co. hitting the daily limit, while others like Guibao Pet and Ketaobiotech rose over 10% [12][13] - The sector ultimately closed up over 5%, driven by the recent success of the "Traini Dog Language Translator" and strong earnings reports from Zhongchong Co. [14][16] Performance of Specific Stocks - Stocks like Lakala and Xinyada saw declines of over 10%, while only Hailian Jinhui managed to maintain a four-day limit-up streak amidst a broader market downturn [8] - The performance of stocks in the pet economy and cross-border payment sectors reflects a trend of short-lived rallies followed by corrections [16] Earnings Disappointments - Several companies are facing significant earnings-related issues, with Baoying Co. and Jiangsu Wuzhong both facing potential ST status due to negative earnings revisions and disclosure violations [22][24] - Jinlitai's inability to disclose its periodic report on time has led to a 20% limit down, despite previous positive earnings forecasts [24][26]
阿尔茨海默概念涨1.30%,主力资金净流入10股
Zheng Quan Shi Bao Wang· 2025-04-24 09:53
Group 1 - The Alzheimer's concept sector rose by 1.30%, ranking 6th among concept sectors, with 21 stocks increasing in value [1][2] - Notable gainers in the sector included Jinkai Biotechnology with a 20% limit-up, Shuangcheng Pharmaceutical also hitting the limit-up, and LuKang Pharmaceutical, Fujilai, and Dongcheng Pharmaceutical with increases of 3.95%, 3.60%, and 2.06% respectively [1][2] - The sector experienced a net inflow of 250 million yuan from main funds, with Shuangcheng Pharmaceutical leading the inflow at 181 million yuan [2][3] Group 2 - The top stocks by net inflow ratio included Jinkai Biotechnology at 33.12%, Shuangcheng Pharmaceutical at 19.33%, and Chitianhua at 5.51% [3] - The trading volume and turnover rates for key stocks in the Alzheimer's concept were significant, with Shuangcheng Pharmaceutical showing a turnover rate of 23.40% and Jinkai Biotechnology at 23.43% [3] - Decliners in the sector included NuoVizon, Dean Diagnostics, and BGI Genomics, with declines of 2.96%, 2.68%, and 1.85% respectively [1][4]
4月24日主题复盘 | 电力、医药再度走强,宠物经济迎来爆发,大消费尾盘上演反包行情
Xuan Gu Bao· 2025-04-24 09:18
一、行情回顾 市场全天冲高回落,三大指数涨跌互现。宠物消费概念走强,天元宠物、中宠股份、依依股份涨停。电力股集体拉升,乐山电力、华银电力、西昌电力等封 板。多只高位股尾盘走出反包走势,安记食品、国芳集团均上演地天板。个股跌多涨少,沪深京三市超3800股飘绿,今日成交1.14万亿。截止收盘沪指涨 0.03%,深成指跌0.58%,创业板指跌0.68%。 | 风口板块 更多 | | | | | | 涨跌幅榜 更多 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 宠物经济 | +5.03% | 电力体制改革 | +2.24% | 医药 | +0.62% | 宠物经济 | PEEK材料 | 水电 | 征信概念 | 次新股 | | 跨物种翻译器Traini近一年增长 | | 頁季用电高峰即将来临 | | 创新药龙头创历史新高 | | +5.03% | +4.08% | +3.67% | -3.84% | -3.84% | | 四倍 | | | | | | 异内藤 | 火电 | 制冷剂 | 跨境支付 | web3 ...
CRO概念涨0.96%,主力资金净流入31股
Zheng Quan Shi Bao Wang· 2025-04-24 08:54
截至4月24日收盘,CRO概念上涨0.96%,位居概念板块涨幅第9,板块内,38股上涨,金凯生科20%涨 停,双成药业、河化股份、凯莱英等涨停,峆一药业、博腾股份、昊帆生物等涨幅居前,分别上涨 6.50%、5.35%、4.50%。跌幅居前的有星昊医药、康鹏科技、蔚蓝生物等,分别下跌8.43%、4.30%、 3.46%。 今日涨跌幅居前的概念板块 | 业 | | --- | | 603259 | 药明康 | 0.36 | 1.49 | 2800.31 | 1.32 | | --- | --- | --- | --- | --- | --- | | | 德 | | | | | | 300363 | 博腾股 | 5.35 | 5.1 1 | 2230.39 | 5.99 | | | 份 | | | | | | 300725 | 药石科 | 0.38 | 4.14 | 1420.31 | 6.43 | | | 技 | | | | | | 300347 | 泰格医 | 0.35 | 1.99 | 1315.18 | 2.54 | | | 药 | | | | | | | 圣诺生 | | | | | | 688117 | ...
医药生物行业今日净流入资金2.65亿元,双成药业等10股净流入资金超5000万元
Zheng Quan Shi Bao Wang· 2025-04-24 08:50
沪指4月24日上涨0.03%,申万所属行业中,今日上涨的有10个,涨幅居前的行业为美容护理、银行, 涨幅分别为1.61%、1.16%。医药生物行业今日上涨0.25%。跌幅居前的行业为计算机、通信,跌幅分别 为2.36%、2.08%。 主力资金净流出的行业有25个,电子行业主力资金净流出规模居首,全天净流出资金66.21亿元,其次 是计算机行业,净流出资金为64.60亿元,净流出资金较多的还有机械设备、通信、汽车等行业。 医药生物行业今日上涨0.25%,全天主力资金净流入2.65亿元,该行业所属的个股共476只,今日上涨的 有243只,涨停的有10只;下跌的有218只,跌停的有3只。以资金流向数据进行统计,该行业资金净流 入的个股有204只,其中,净流入资金超5000万元的有10只,净流入资金居首的是双成药业,今日净流 入资金1.81亿元,紧随其后的是凯莱英、金凯生科,净流入资金分别为1.63亿元、1.37亿元。医药生物 行业资金净流出个股中,资金净流出超3000万元的有9只,净流出资金居前的有花园生物、迈瑞医疗、 智飞生物,净流出资金分别为8240.77万元、6250.66万元、6132.45万元。(数据宝) ...
双成药业今日涨停,有1家机构专用席位净卖出1141.06万元
news flash· 2025-04-24 08:26
双成药业(002693)今日涨停,成交额9.36亿元,换手率23.40%,盘后龙虎榜数据显示,深股通专用席 位买入1.24亿元并卖出3252.46万元,有1家机构专用席位净卖出1141.06万元。 ...
CRO概念股盘初拉升,金凯生科20cm涨停
news flash· 2025-04-24 01:36
暗盘资金正涌入这些股票,点击速看>>> CRO概念股盘初拉升,金凯生科(301509)20cm涨停,双成药业(002693)逼近涨停,昊帆生物 (301393)、凯莱英(002821)、泓博医药(301230)上扬。 ...
连遭3个跌停!“前10倍牛”人气骤降,多只高标陷入回撤,这些也遭“亏钱效应”
Xin Lang Cai Jing· 2025-04-23 09:47
| | 日期:2025-04-22 总成交金额:158369.84万元,总成交量:12278.04万股 | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 排序 | 营业部名称 | 买入金额/万 | 占总成交比例 | 卖出金额/万 | 占总成交比例 | 净额/万 | | | ■ 买入金额量大的前5名 买入总计 1896.87 万元,占总成交比例 1.20% | | | | | | | | 中国银河证券股份有限公司北京中关村大街证券营业部 | 504.50 | 0.32% | 0.12 | 0.00% | 504.38 | | 2 | 中国银河亚群股份有限公司永康五洲路正新疆业部 | 442.28 | 0.28% | 396.07 | 0.25% | 46.21 | | m | 中国中全财富亚券有限公司 1657 73 11 47 11 | 392.56 | 0.25% | 2.60 | 0.00% | 389.97 | | র্ব | 东北证券股份有限公司因 行分公司 | 278.48 | 0.18% | 0.71 | 0.00% | 277.7 ...
海南双成药业股份有限公司 股票交易异常波动及风险提示性公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-04-23 01:07
重要风险提示: 1、公司于2025年1月18日在《中国证券报》《证券时报》和巨潮资讯网(www.cninfo.com.cn)披露了 《2024年度业绩预告》(公告编号:2025-003)。经公司财务部门初步测算(未经审计),预计公司 2024年度归属于上市公司股东的净利润为负值,且扣除后营业收入为14,000万元至18,000万元。根据 《深圳证券交易所股票上市规则》的相关规定,公司股票交易将在2024年年度报告披露后可能被实施退 市风险警示(股票简称前冠以"*ST"字样)。敬请广大投资者注意投资风险。 2、股票异常波动风险 公司分别于2025年4月15日、2025年4月17日披露《股票交易异常波动及风险提示性公告》(公告编号: 2025-015、2025-016)。公司股票(证券简称:双成药业,证券代码:002693)收盘价格涨幅偏离值累 计达到深圳证券交易所的有关规定属于股票交易异常波动情况。近期,公司股票交易价格发生较大波 动,敬请广大投资者注意二级市场交易风险,理性决策,审慎投资。 登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假记载 ...